Hydramine and Mucosal erosion - a phase IV clinical study of FDA data

Summary:

Mucosal erosion is reported as a side effect among people who take Hydramine (diphenhydramine hydrochloride), especially for people who are female, 30-39 old, also take Xalatan, and have Cellulitis.

The phase IV clinical study analyzes which people have Mucosal erosion when taking Hydramine. It is created by eHealthMe based on reports of 113,450 people who have side effects when taking Hydramine from the FDA, and is updated regularly.

What is Hydramine?

Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 114,900 Hydramine users. Check the latest studies of Hydramine.

What is Mucosal erosion?

Mucosal erosion (peeling off of mucous membrane) is found to be associated with 212 drugs and 400 conditions by eHealthMe. Check the latest studies of Mucosal erosion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

113,450 people reported to have side effects when taking Hydramine.
Among them, 11 people (0.01%) have Mucosal erosion.

Among these 11 people:

What is the gender of people who have Mucosal erosion when taking Hydramine? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Mucosal erosion when taking Hydramine? *

What are other drugs people take besides Hydramine? *

What are other side effects people have besides Mucosal erosion? *

Lymphoedema (localized fluid retention and tissue swelling): 6 people, 54.55%
Lip Pain: 4 people, 36.36%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 36.36%
Pain In Extremity: 4 people, 36.36%
Hypotension (abnormally low blood pressure): 4 people, 36.36%
Erythema Multiforme (a type of hypersensitivity reaction): 4 people, 36.36%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 4 people, 36.36%
Localised Infection (infection at the single location): 4 people, 36.36%
Weight Decreased: 4 people, 36.36%
Jaw Disorder (jaw disease): 3 people, 27.27%

What are the existing conditions these people have? *

Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 4 people, 36.36%
Cellulitis (infection under the skin): 4 people, 36.36%
Metastases To Bone (cancer spreads to bone): 3 people, 27.27%
Breast Cancer Metastatic: 3 people, 27.27%
Breast Cancer: 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Hydramine and have Mucosal erosion?

- Check whether Mucosal erosion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hydramine:

Hydramine (114,900 reports)

Mucosal erosion treatments and more:

Mucosal erosion (1,167 reports)

Browse all side effects of Hydramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mucosal erosion:

Mucosal erosion (212 drugs)

Browse all the conditions that are associated with Mucosal erosion:

Mucosal erosion (400 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride (the active ingredients of Hydramine) and Hydramine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.